Phytochemical Approach and Bioanalytical Strategy to Develop Chaperone-Based Medications
Correspondence: (Login to view email address)
- Research Centre Juelich, Institute Phytosphere (ICG-3), Germany
PDF (580.5 KB)
This manuscript is a preprint. A published version is available at:
10.2174/1874091X00802010044 (Peer Reviewed) The Open Biochemistry Journal (2008), 2, 44-48- Document Type:
- Manuscript
- Date:
- Received 08 April 2008 16:45 UTC; Posted 09 April 2008
- Subjects:
- Chemistry, Pharmacology, Plant Biology
- Abstract:
Currently, no pharmaceuticals for the etiological treatment of degenerative protein-misfolding diseases (e.g., ALS, Alzheimer’s or prion diseases) are commercially available. Therefore, in this technical note theoretical considerations and practical approaches concerning the development of chaperone-based medications from medicinal plants (e.g., Ginkgo biloba) are reviewed and discussed in detail. Phytochaperones and other agents isolated from medicinal plants are proposed to serve as the general basis of drug development in protein-misfolding diseases.
Discussion
- Votes:
-
0 votes
- Comments:
-
0 comments
- (Login to share with a colleague)
Additional information
- License:
- This document is licensed to the public under the Creative Commons Attribution 3.0 License
- How to cite this document:
-
Kastenholz, Bernd. Phytochemical Approach and Bioanalytical Strategy to Develop Chaperone-Based Medications. Available from Nature Precedings <http://hdl.handle.net/10101/npre.2008.1431.2> (2008)
- Version info:
-
Published version:
10.2174/1874091X00802010044 (Peer Reviewed) The Open Biochemistry Journal (2008), 2, 44-48 -
Other versions of this document in Nature Precedings
Version number Document title Date v1 Posted 18 December 2007 Other versions of this document elsewhere on the web
None known.
